ProHealth materials indicate that each batch undergoes triple third-party lab testing - tested three separate times by independent laboratories for identity, purity, and potency
In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss
Cost Factor: The medications can be expensive
GLP-1 receptors sit in the brain's reward circuitry (the ventral tegmental area and nucleus accumbens), and activating them appears to blunt the dopamine hit that makes alcohol reinforcing i.e., it turns down craving
If you know what to expect, you will not panic at the first shedding and can better judge whether everything is within the expected range
GHK-Cu, BPC-157, and TB-500 have not done this for human therapeutic indications